* SI-BONE Inc SIBN.OQ reported a quarterly adjusted loss
of 27
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -32
cents. The mean expectation of eight analysts for the quarter
was for a loss of 28 cents per share. Wall Street expected
results to range from -31 cents to -23 cents per share.
* Revenue rose 21.6% to $38.86 million from a year ago;
analysts
expected $37.61 million.
* SI-BONE Inc's reported EPS for the quarter was a loss
of 27
cents.
* The company reported a quarterly loss of $10.98 million.
* SI-BONE Inc shares had fallen by 3.4% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for SI-BONE Inc is
$26.00
This summary was machine generated from LSEG data February 26 at
10:51 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.28 -0.27 Beat
Sep. 30 2023 -0.34 -0.25 Beat
Jun. 30 2023 -0.40 -0.30 Beat
Mar. 31 2023 -0.41 -0.32 Beat